[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369781-105":59,"doc-detail-369781-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-immune-related-prognostic-gene-aim2-promotes-pancreatic-cancer-progression-via-inflammasome","The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome","","Immune-related factors are closely linked to tumor progression and responses to immunotherapy in pancreatic cancer. This study constructs an immune-related prognostic gene (IRGP) model using LASSO Cox regression and determines each gene’s contribution. Prognostic performance is validated by ROC and Kaplan–Meier analyses, with additional investigation of immune cell infiltration associations. Nine genes form the optimal signature, distinguishing high- vs low-risk groups and showing superior prognostic utility to TNM staging, with higher-risk patients exhibiting shorter overall survival and reduced infiltration of 24 immune cell types. AIM2 is further explored as a potential driver of inflammatory tumor microenvironments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-immune-related-prognostic-gene-aim2-promotes-pancreatic-cancer-progression-via-inflammasome/369781/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-immune-related-prognostic-gene-aim2-promotes-pancreatic-cancer-progression-via-inflammasome/369781.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the immune-related prognostic model for pancreatic cancer constructed?","Question",{"text":112,"@type":113},"The study built an IRGP model by selecting immune-related genes and estimating their contributions using coefficients from LASSO Cox regression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the prognostic signatures validated?",{"text":117,"@type":113},"Validation used ROC curve analysis and Kaplan–Meier survival analysis to assess whether the signature accurately separates prognostic outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between the IRGP risk groups and immune cell infiltration?",{"text":121,"@type":113},"High-risk patients showed shorter overall survival and lower infiltration levels across 24 immune cell types compared with low-risk patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369781,1790210583,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome  \nLin Liang1,2, Yanhong Zhou2, Yang Zhang2, Shuangyan Ou1, Zhijun Yuan1, Hong Yi3􀀍 & Xia Yuan1􀀍  \nImmune-related factors are closely associated with tumor progression and responses to immunotherapy. A systematic analysis of the immunogenomic landscape and the identification of key immune-related genes (IRGs) can contribute to a better understanding of pancreatic cancer. To identify immune-related genetic prognostic characteristics (IRGPs) of pancreatic cancer, we first constructed an IRGP model containing multiple immune-related genes and determined the relative contributions of each gene using coefficients from the Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression analysis. Subsequently, the prognostic value of the signature was validated through receiver operating characteristic (ROC) curve analysis and Kaplan-Meier survival analysis. Additionally, we explored the potential relationship between IRGPs and immune cell infiltration. Nine gene prognostic features were identified as the optimal IRGPs, which include six high-risk genes and three low-risk genes. Principal Component Analysis (PCA) demonstrated that this feature can effectively distinguish between high-risk and low-risk groups. The area under the curve (AUC) value indicated that IRGPs provide better prognostic clinical utility compared to existing TNM staging classifications. The median overall survival (OS) of high-risk patients was significantly shorter, and the infiltration levels of 24 immune cell types were lower. This study identified nine genes that have been identified as important prognostic biomarkers with immune-related characteristics for pancreatic cancer. Furthermore, we also explored the role of AIM2 in pancreatic cancer among the immune-related signature genes.  \nAIM2 may influence the immune invasion and immunotherapy of pancreatic cancer by promoting the inflammatory environment of pancreatic cancer. AIM2 could be a new therapeutic target for pancreatic cancer.  \nKeywords Pancreatic cancer, Immune-related genes, Prognostic signature, Tumor microenvironment, Immune infiltration, AIM2, Inflammasome  \nPancreatic cancer has the poorest prognosis among all solid malignancies, with a median survival time of 6 months1. Over the past decades, both the incidence rate and mortality of pancreatic cancer have been rising steadily2,3. It is estimated that by 2030, pancreatic cancer will become the second leading cause of cancer deaths in the United States4. This highly fatal malignant tumor is characterized by a lack of specific symptoms and no reliable early detection methods. Approximately 80-85% of patients are diagnosed with locally advanced disease or distant metastasis, which makes surgical intervention infeasible5,6. It is reported that only 15-20% of pancreatic tumors can be completely removed by surgery, and patients often experience local or distant recurrence within 2 years after surgery7–10. Systemic chemotherapy is currently the mainstay of treatment for advanced pancreatic cancer; however, due to the chemorefractory nature of the disease, most patients die within 12 months of diagnosis11. Therefore, there is an urgent need to explore reliable and non-invasive prognostic biomarkers to guide decision-making and treatment optimization. Although the current TNM staging system remains the standard for predicting the prognosis of patients with solid malignancies, including pancreatic cancer, patients  \n1Gastroenterology and Urology Department II, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha 410013, Hunan, China. 2Cancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China. 3Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hos","cbCailRCADa5dFva","https://ap.wps.com/l/cbCailRCADa5dFva","pdf",15950189,17,"English","# Construction and validation of immune-related prognostic signatures\n## Risk scoring and survival analyses\n## Immune infiltration associations\n# Identification of AIM2 in pancreatic cancer progression","[{\"question\":\"How was the immune-related prognostic model for pancreatic cancer constructed?\",\"answer\":\"The study built an IRGP model by selecting immune-related genes and estimating their contributions using coefficients from LASSO Cox regression.\"},{\"question\":\"How were the prognostic signatures validated?\",\"answer\":\"Validation used ROC curve analysis and Kaplan–Meier survival analysis to assess whether the signature accurately separates prognostic outcomes.\"},{\"question\":\"What is the relationship between the IRGP risk groups and immune cell infiltration?\",\"answer\":\"High-risk patients showed shorter overall survival and lower infiltration levels across 24 immune cell types compared with low-risk patients.\"}]","The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome | PDF",1790184515,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27717f5f7751028db464ad48150e1c1e.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31f122507f0331e31715967155ed7932.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff12872db1cf3e046491d85bf29498b3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32571ce585fa012512454fa8ade7cd65.webp",980,1287]